Pfizer: The Most Intriguing Value Play Of 2026 (NYSE:PFE)

Pfizer (NYSE: PFE ) has been a strong conviction pick of mine for a while now, and since my latest analysis , which pointed to what should go right for the company, has beenAs a detail-oriented investor with a strong foundation in finance and business writing, I focus on analyzing undervalued and disliked companies or industries that have strong fundamentals and good cash flows. I have a particular interest in sectors such as Oil&Gas and consumer goods. Basically, anything that has been unloved for unjustif ...